Muscular atrophy is the loss of muscular tissue due to disuse, injury, or disease. Individuals are most likely to develop muscular atrophy from aging, malnutrition, lack of physical activity, stroke, or injury, or from diseases such as multiple sclerosis, osteoarthritis, polio, or muscular dystrophy. Muscle atrophy develops over time, but the more severe type, called neurogenic atrophy, occurs more suddenly because it is caused by damage to the nerve connection to a muscle. Many cases of muscular atrophy can be reversed through treatment. Treatments include physical therapy, ultrasound therapy, and surgery.
Muscular Atrophy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Atrophy below!
For more information on how to use Laverne, please read the How to Guide.
We have 1942 products for the study of Muscular Atrophy that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.